TEL AVIV, Israel, May 17, 2023 /PRNewswire/ -- Arbe Robotics Ltd. (NASDAQ: ARBE) ("Arbe"), a global leader in perception radar solutions, today announced financial results for its first quarter, which ended March 31, 2023.
Key Q1 and Recent Company Highlights:
This quarter, significant steps have been taken towards production and revenue growth through collaboration with Tier 1s and leading car manufacturers aiming to adopt Arbe's technology for enhancing safety and autonomy in their next-generation platforms.
"We are proud of the progress that we made in the first quarter, highlighted by the successful establishment of a production line for radar systems based on our chipsets at Weifu," said Kobi Marenko, Chief Executive Officer. "Arbe and Weifu have signed a strategic agreement with DiDi Global's autonomous freight company, KargoBot. This cooperation platform aims to drive the development of cutting-edge technological products and expedite the commercialization of autonomous driving solutions within the logistics and freight sector.
"Furthermore, we are thrilled by the significant milestones achieved by the Tier 1 suppliers we work with in engaging potential customers across Europe, the U.S., and Asia. These accomplishments instill confidence in our strong position for sustained growth and reaffirm our commitment to securing four OEM selections by the end of 2023," concluded Marenko.
First Quarter 2023 Financial Highlights
Revenues for Q1 2023 were $0.4 million, a decrease from $0.9 million in Q1 2022. Revenue was in line with expectations given Arbe's decision to shift focus to chips for production. Backlog as of March 31, 2023, was $0.4 million, not including the previously announced HiRain preliminary order.
Gross margin for Q1 2023 was 11%, compared to 56.1% in Q1 2022, mainly related to economy of scale.
Operating expenses in Q1 2023 were $10.7 million, compared to $11.1 million in Q1 2022. The decrease in operating expenses was primarily driven by a decrease in general and administrative expenses from $2.1 million in Q1 2022 to $1.6 million in Q1 2023 and a decrease in sales and marketing expenses from $1.2 million in Q1 2022 to $0.9 million in Q1 2023. The decrease was primarily related to favorable exchange rate, and to a lesser extent, due to labor cost.
The decrease was partially offset by an increase in research and development expenses from $7.8 million in Q1 2022 to $8.1 million in Q1 2023. The increase resulted from our continuing investment efforts as we progress toward production, supported by favorable exchange rate impact. As a result, our operating loss remained unchanged from Q1 2022 at $10.6 million.
Net loss in the first quarter of 2023 increased to $9.9 million, compared to a net loss of $7.9 million in the first quarter of 2022. Net loss in Q1 2023 included $0.7 million of financial income, mainly related to favorable exchange rates and interest from deposits. Net loss in Q1 2022 reflected financial income of $2.8 million, mainly related to warrant revaluations.
Adjusted EBITDA, a non-GAAP measurement which excludes financial expense/income and expenses for non-cash share-based compensation and for non-recurring public offering expenses, for Q1 2023, yielded a loss of $8.4 million, compared to a loss of $8.5 million in the first quarter of 2022.
Balance Sheet & Liquidity
As of March 31, 2023, Arbe had $44.9 million in cash and cash equivalents with no debt.
Outlook
Management reiterated the full year outlook for the period ending December 31, 2023. Based on current estimates:
Conference Call & Webcast Details
Arbe will host a conference call and webcast today at 8:30 am ET. Speakers will include Kobi Marenko, Chief Executive Officer, Co-Founder and Director, and Karine Pinto-Flomenboim, Chief Financial Officer. The Company encourages participants to pre-register for the conference call here. Callers will receive a unique dial-in upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.
The live call may be accessed via:
U.S. Toll Free: (833) 316-0562
International: (412) 317-5736
Israel Toll Free: (80) 921-2373
A telephonic replay of the conference call will be available until May 31, 2023, following the end of the conference call. To listen to the replay, please dial:
U.S. Toll Free: (877) 344-7529
International: (412) 317-0088
Access ID: 6476189
A live webcast of the call can be accessed here or from Arbe's Investor Relations website at https://ir.arberobotics.com/news/ir-calendar. An archived webcast of the conference call will also be made available on the website following the call.
About Arbe
Arbe (Nasdaq: ARBE), a global leader in Perception Radar Chipset Solutions, is spearheading a radar revolution, enabling truly safe driver-assist systems today while paving the way to full autonomous-driving. Arbe's imaging radar is 100 times more detailed than any other radar on the market and is a mandatory sensor for L2+ and higher autonomy. The company is empowering automakers, tier-1 suppliers, delivery robots, commercial and industrial vehicles, and a wide array of safety applications with advanced sensing and paradigm-changing perception. Arbe is a leader in the fast-growing automotive radar market that has a projected total addressable market of $11 billion in 2025. Arbe is based in Tel Aviv, Israel, and has an office in the United States.
Cautionary Note Regarding Forward-Looking Statements
This press release and any statements made at the conference call and webcast referred to in this press release, contains "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995. The words "expect," "believe," "estimate," "intend," "plan," "anticipate," "may," "should," "strategy," "future," "will," "project," "potential" and similar expressions indicate forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These risks and uncertainties include, but are not limited to: (i) our ability to obtain design-ins during 2023; (ii) unanticipated delays or difficulties in connection with the evaluation of Arbe's products in evaluation and test programs; (iii) Arbe's ability to have products manufactured for it by its third party supplier that meet Arbe's and its customers quality standards and delivery requirements; (iv) Arbe's ability to leverage its existing relationships and secure orders resulting from the test programs; (v) Arbe's ability to meet its projected revenue level and its ability to operate profitably; (vi) Arbe's ability to meet its timetable both to achieve full production and to meet the delivery requirements of its customers; (vii) the development of safe autonomous vehicles that include Arbe's radar systems; (viii) Arbe's expectation that it will obtain orders from Tier 1 suppliers and automakers that would build the radars based on its Chipset solution; (ix) Arbe's belief that the Arbe Radar Chipset and Lynx Surround Imaging Radar herald a breakthrough in radar technology that provide Tier 1 suppliers and automakers with the ability to replace the current radars with an advanced solution that meets the safety requirements of Euro-NCAP and NHTSA for autonomous vehicles at all levels of autonomous driving; (x) the ability of its Tier 1 customers to successfully market radar systems using Arbe's radar to automobile manufacturers; (xi) Arbe's ability to develop and market products based on its radar technology for uses outside of the automotive industry; (xii) accidents or bad press resulting from accidents involving autonomous driving vehicles, even those using radar products from other companies or based on other technology and the effect of any accidents with vehicles using Arbe's radar system; (xiii) the effect of laws and changes in laws that have an effect on the market for or the requirement for autonomous vehicles; (xiv) Arbe's belief that an increased demand for autonomous vehicles and the transition to mass production of Level 2 and higher autonomous vehicles, requiring advanced systems for automatically integrating vehicles in traffic and preventing traffic accidents, are expected to increase the demand for products in Arbe's field of activity; (xv) changes or inaccuracies in market projections; and (xvi) the risk and uncertainties described in "Cautionary Note Regarding Forward-Looking Statements," "Item 5. Operating and Financial Review and Prospects" and Item 3. Key Information –Risk Factors" in Amendment No. 1 to Arbe's Annual Report on Form 20-F/A for the year ended December 31, 2022, which was filed with the Securities and Exchange Commission on May 9, 2023 as well as other documents filed by Arbe with the SEC. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and Arbe does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.
Information contained on, or that can be accessed through, Arbe's website or any other website is expressly not incorporated by reference into and is not a part of this press release.
CONSOLIDATED BALANCE SHEETS | ||||
(U.S. dollars in thousands) | ||||
March 31, 2023 | December 31, 2022 | |||
Current Assets: | (Unaudited) | (Unaudited) | ||
Cash and cash equivalents | 44,903 | 54,171 | ||
Restricted cash | 135 | 144 | ||
Short term bank deposits | - | 400 | ||
Trade receivable | 2,088 | 2,202 | ||
Prepaid expenses and other receivables | 1,665 | 1,839 | ||
Total current assets | 48,791 | 58,756 | ||
Non-Current Assets | ||||
Operating lease right-of-use assets | 453 | 465 | ||
Property and equipment, net | 1,573 | 1,609 | ||
Total non-current assets | 2,026 | 2,074 | ||
Total assets | 50,817 | 60,830 | ||
Current liabilities: | ||||
Trade payables | 2,145 | 1,244 | ||
Operating lease liabilities | 328 | 364 | ||
Employees and payroll accruals | 2,268 | 2,861 | ||
Deferred revenues | 351 | 351 | ||
Accrued expenses and other payables | 2,402 | 5,609 | ||
Total current liabilities | 7,494 | 10,429 | ||
Long term liabilities | ||||
Operating lease liabilities | 49 | 17 | ||
Warrant liabilities | 1,762 | 1,631 | ||
Total long-term liabilities | 1,811 | 1,648 | ||
SHAREHOLDERS' EQUITY: | ||||
Ordinary Shares | *) | *) | ||
Additional paid-in capital | 211,559 | 208,893 | ||
Accumulated deficit | (170,047) | (160,140) | ||
Total shareholders' equity | 41,512 | 48,753 | ||
Total liabilities and shareholders' equity | 50,817 | 60,830 | ||
*) Represents less than $1. |
CONSOLIDATED STATEMENTS OF OPERATIONS | |||||
(U.S. dollars in thousands, except share and per share data) | |||||
3 Months Ended | 3 Months Ended | ||||
March 31, 2023 | March 31, 2022 | ||||
(Unaudited) | (Unaudited) | ||||
Revenues | 355 | 876 | |||
Cost of revenues | 316 | 384 | |||
Gross Profit | 39 | 492 | |||
Operating Expenses: | |||||
Research and development, net | 8,124 | 7,803 | |||
Sales and marketing | 924 | 1,182 | |||
General and administrative | 1,630 | 2,145 | |||
Total operating expenses | 10,678 | 11,130 | |||
Operating loss | (10,639) | (10,638) | |||
Financial income, net | (732) | (2,782) | |||
Net loss | (9,907) | (7,856) | |||
Basic net loss per ordinary share | (0.15) | (0.12) | |||
Weighted-average number of | 64,671,688 | 63,034,545 | |||
Diluted net loss per ordinary share | (0.17) | (0.12) | |||
Weighted-average number of | 58,969,265 | 63,034,545 | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||
(U.S. dollars in thousands) | ||||||
3 Months Ended | 3 Months Ended | |||||
March 31, 2023 | March 31, 2022 | |||||
Cash flows from operating activities: | (Unaudited) | (Unaudited) | ||||
Net Loss | (9,907) | (7,856) | ||||
Adjustments to reconcile loss to net cash used in operating activities: | ||||||
Depreciation | 137 | 105 | ||||
Stock-based compensation | 2,008 | 1,790 | ||||
Warrants to service providers | 97 | 69 | ||||
Revaluation of warrants and accretion | 131 | (3,135) | ||||
Change in operating assets and liabilities: | ||||||
Decrease (increase) in trade receivable | 114 | (465) | ||||
Decrease (increase) in prepaid expenses and other receivables | 174 | (339) | ||||
Operating lease ROU assets and liabilities, net | 8 | (16) | ||||
Increase (decrease) in trade payables | 853 | (668) | ||||
Increase (decrease) in employees and payroll accruals | (593) | 372 | ||||
Increase (decrease) in deferred revenue | - | 5 | ||||
decrease in accrued expenses and other payables | (3,207) | (2,865) | ||||
Net cash used in operating activities | (10,185) | (13,003) | ||||
Cash flows from investing activities: | ||||||
Change in bank deposits | 400 | (400) | ||||
Purchase of property and equipment | (53) | (242) | ||||
Net cash provided by (used in) investing activities | 347 | (642) | ||||
Cash flows from financing activities: | ||||||
Proceeds from exercise of options | 561 | 96 | ||||
Net cash provided by financing activities | 561 | 96 | ||||
Effect of exchange rate fluctuations on cash and cash equivalent | 509 | 65 | ||||
Decrease (Increase) in cash, cash equivalents and restricted cash | (9,786) | (13,614) | ||||
Cash, cash equivalents and restricted cash at the beginning of | 54,315 | 100,936 | ||||
Cash, cash equivalents and restricted cash at the end of period | 45,038 | 87,387 | ||||
RECONCILIATION OF GAAP NET LOSS TO NON-GAAP NET LOSS | |||||||
(U.S. dollars in thousands, except share and per share data) | |||||||
3 Months Ended | 3 Months Ended | ||||||
March 31, 2023 | March 31, 2022 | ||||||
GAAP net loss attributable to ordinary shareholders | (9,907) | (7,856) | |||||
Add: | |||||||
Stock-based compensation | 2,008 | 1,790 | |||||
Warrants to service providers | 97 | 69 | |||||
Revaluation of warrants and accretion | 131 | (3,135) | |||||
Non-recurring initial public offering expenses | - | 130 | |||||
Non-GAAP net loss | (7,671) | (9,002) | |||||
Basic Non-GAAP net loss per ordinary share | (0.12) | (0.14) | |||||
Weighted-average number of shares used in computing basic Non-GAAP net loss per ordinary share | 64,671,688 | 63,034,545 | |||||
Diluted Non-GAAP net loss per ordinary share | (0.13) | (0.14) | |||||
Weighted-average number of shares used in computing diluted Non-GAAP net loss per ordinary share | 58,969,265 | 63,034,545 | |||||
RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA | |||||||
(U.S. dollars in thousands) | |||||||
3 Months Ended | 3 Months Ended | ||||||
March 31, 2023 | March 31, 2022 | ||||||
GAAP net loss attributable to ordinary shareholders | (9,907) | (7,856) | |||||
Add: | |||||||
Financial expenses (income), net | (732) | (2,782) | |||||
Depreciation | 137 | 105 | |||||
Stock-based compensation | 2,008 | 1,790 | |||||
Warrants to service providers | 97 | 69 | |||||
Non-recurring initial public offering expenses | - | 130 | |||||
Adjusted EBITDA | (8,397) | (8,544) | |||||
Last Trade: | US$2.19 |
Daily Change: | 0.39 21.67 |
Daily Volume: | 8,499,953 |
Market Cap: | US$186.610M |
November 04, 2024 September 26, 2024 September 04, 2024 August 06, 2024 July 11, 2024 |
Else Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...
CLICK TO LEARN MORENorthstar Clean Technologies is a cleantech company focused on the sustainable recovery and reprocessing of asphalt shingles. Northstar’s mission is to be the leader in the recovery and reprocessing of asphalt shingles in North America...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS